KELLY BRILLANT: Open Payments
NPI 1467785774 · WASHINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,298 in 67 payments from 15 companies in 2025. Trend: 2023 $406 · 2024 $530 · 2025 $1,298
Food & beverage: $1,298
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $437 |
| QOL Medical, LLC | 8 | $159 |
| Aimmune Therapeutics, Inc. | 5 | $108 |
| GENZYME CORPORATION | 3 | $83 |
| PFIZER INC. | 5 | $77 |
| Lilly USA, LLC | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Madrigal Pharmaceuticals | 3 | $69 |
| Intercept Pharmaceuticals, Inc. | 3 | $55 |
| Gilead Sciences, Inc. | 2 | $53 |
Products named: RINVOQ, Sucraid, DUPIXENT, ZENPEP, OMVOH, REZDIFFRA, CREON, MAVYRET.
Industry payments across NC — which companies pay providers there.
